TRDA Collar Strategy
TRDA (Entrada Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Entrada Therapeutics, Inc. operates as a biotechnology enterprise dedicated to pioneering endosomal escape vehicle (EEV) therapeutics, specifically engineered to tackle a range of neuromuscular ailments. The company leverages its proprietary EEV platform to cultivate a rich pipeline of therapeutic programs, integrating oligonucleotide, antibody, and enzyme-based approaches. Its foremost product candidate, ENTR-601-44, is currently undergoing preclinical assessment for its potential in addressing both Duchenne muscular dystrophy and myotonic dystrophy type 1. Furthermore, Entrada is actively developing EEV-PMO-CAG, also targeting myotonic dystrophy type 1. Incorporated in 2016, the firm was formerly known as CycloPorters, Inc., before officially changing its name to Entrada Therapeutics, Inc. in October 2017. The company maintains its corporate headquarters in Boston, Massachusetts.
TRDA (Entrada Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $300.5M, a beta of -0.26 versus the broader market, a 52-week range of 4.93-16.45, average daily share volume of 369K, a public-listing history dating back to 2021, approximately 183 full-time employees. These structural characteristics shape how TRDA stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of -0.26 indicates TRDA has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a collar on TRDA?
A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot.
Current TRDA snapshot
As of June 30, 2026, spot at $7.38, ATM IV 117.50%, IV rank 21.14%, expected move 33.69%. The collar on TRDA below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this collar structure on TRDA specifically: IV regime affects collar pricing on both sides; compressed TRDA IV at 117.50% typically pushes the short call premium to roughly offset the long put cost, with a market-implied 1-standard-deviation move of approximately 33.69% (roughly $2.49 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated TRDA expiries trade a higher absolute premium for lower per-day decay. Position sizing on TRDA should anchor to the underlying notional of $7.38 per share and to the trader's directional view on TRDA stock.
TRDA collar setup
The TRDA collar below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With TRDA near $7.38, the first option leg uses a $7.75 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed TRDA chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 TRDA shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $7.38 | long |
| Sell 1 | Call | $7.75 | N/A |
| Buy 1 | Put | $7.01 | N/A |
TRDA collar risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium.
TRDA collar payoff curve
Modeled P&L at expiration across a range of underlying prices for the collar on TRDA. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use collar on TRDA
Collars on TRDA hedge an existing long TRDA stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
TRDA thesis for this collar
The market-implied 1-standard-deviation range for TRDA extends from approximately $4.89 on the downside to $9.87 on the upside. A TRDA collar hedges an existing long TRDA position with a protective put while financing the put cost via a short call; when the premiums roughly offset, the collar acts as a near-zero-cost insurance band around the current spot. Current TRDA IV rank near 21.14% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on TRDA at 117.50%. As a Healthcare name, TRDA options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to TRDA-specific events.
TRDA collar positions are structurally neutral (protective); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. TRDA positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move TRDA alongside the broader basket even when TRDA-specific fundamentals are unchanged. Always rebuild the position from current TRDA chain quotes before placing a trade.
Frequently asked questions
- What is a collar on TRDA?
- A collar on TRDA is the collar strategy applied to TRDA (stock). The strategy is structurally neutral (protective): A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot. With TRDA stock trading near $7.38, the strikes shown on this page are snapped to the nearest listed TRDA chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are TRDA collar max profit and max loss calculated?
- Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the TRDA collar priced from the end-of-day chain at a 30-day expiry (ATM IV 117.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a TRDA collar?
- The breakeven for the TRDA collar priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current TRDA market-implied 1-standard-deviation expected move is approximately 33.69%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a collar on TRDA?
- Collars on TRDA hedge an existing long TRDA stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
- How does current TRDA implied volatility affect this collar?
- TRDA ATM IV is at 117.50% with IV rank near 21.14%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.